Patent · US Active

6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders

US8680099B2 · kind B2 · utility

2Cited by
0References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2011
Grant dateMar 25, 2014
Priority date—
Expiry dateJun 10, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.